Other disclosuresBSE · 524824
Bal Pharma Ltd
Bal Pharma Ltd - 524824 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
01 / The disclosure
What the company shared
Compliance Certificate under Reg 74 (5) of SEBI (DP) Regulation 2018 for the quarter ended 30th September 2026
Exchange-provided summary Company profile
A question for your research
Read the underlying filing for the complete disclosure and any conditions not included in the exchange summary.
Disclosed period ended 2026-09-30 · Q2 FY2027The evidence
Read the source excerpts
PDF text extraction is queued. The summary above comes from the exchange listing.
Source & verificationView the disclosure trail
- Summary method
- Exchange-provided text; no generated financial figures
- Exchange identifier
- b83bd4ad-e7ca-4416-b24b-9e26f1964948
- First collected
- 7 Oct 2026, 21:05 IST
- PDF extraction
- pending
You’ve reached the end of this disclosure.